Paving the way for access to innovative cell and gene therapies in China
Dr. Vas Narasimhan
CEO Novartis
Executive Summary
A favourable policy environment in this field will also further support investments in China, i.e. more drug researchers with a global vision and experience will come to China to develop cell and gene therapies. In addition, raising standards in the various areas related to cell and gene therapies will support the government’s aim to take over an international leading role in this field.
附件下载:Paving the way for access to innovative cell and gene therapies in China